Shox2: A Key Player in Beiging ResponseAdipocytr in Adipocyte Beiging Response

Adipose Tissue: Brown, Beige, and White

• Adipose tissues come in three main types with distinct roles and morphologies: brown adipose tissue (BAT), beige (or brite/beiging-prone) adipocytes, and white adipose tissue (WAT).

• Neonatal BAT activity is described as being “between the shoulder blades,” with Brow adipose tissue activity decreasing or changing location with growth; in adults, there is an active pocket around the collarbones. The key difference among adipocyte types is how they handle energy: BAT and beige cells dissipate chemical energy as heat, while white adipocytes mainly store energy.

• UCP1 (uncoupling protein 1) is central to brown/beige thermogenesis. BAT contains multiple small lipid droplets and high mitochondrial density with UCP1 located in mitochondria. White adipocytes have a single large lipid droplet (unilocular) and fewer mitochondria, focusing on energy storage rather than heat production.

• Beige adipocytes are a hybrid phenotype that can be induced in white adipose tissue under certain conditions, notably cold exposure or pharmacologic stimulation, and can interconvert with white adipocytes depending on physiological cues.

Molecular basis of thermogenesis in brown/beige adipocytes

• UCP1 functions by uncoupling oxidative phosphorylation from ATP synthesis. It uses the proton gradient across the inner mitochondrial membrane to generate heat instead of producing ATP. In formula form, the proton motive force Δp drives either ATP synthesis or heat production via UCP1; when UCP1 activity predominates, energy is released as heat rather than being captured as ATP.

• In brown adipocytes, energy released from fatty acid oxidation is channeled to heat production through UCP1. Beige adipocytes can express UCP1 under beiging stimuli and contribute to non-shivering thermogenesis.

• Beige adipocytes are not fixed: they arise from precursor populations or via transdifferentiation of mature white adipocytes, and their thermogenic capability can be modulated by environmental and hormonal cues.

Beiging and energy metabolism: signaling and cellular plasticity

• Cold exposure or analogous stimuli trigger the hypothalamus to sense energy-carrying signals and activate the sympathetic nervous system. This leads to the release of norepinephrine (NE) which binds to beta-adrenergic receptors on adipocytes.

• Beta-adrenergic signaling activates the cyclic adenosine monophosphate (cAMP) pathway, which in turn activates downstream effectors to promote beiging and glycolysis, increasing energy expenditure and heat generation. In biochemical terms:
  \text{NE} \rightarrow \beta\text{-adrenergic receptor activation} \rightarrow cAMP \rightarrow \text{PKA} \rightarrow \text{expression of beiging genes and glycolytic enzymes}.

• In vitro, agents that modulate adipogenesis can influence beiging. Rosiglitazone (TZD), a PPARγ agonist, can bind PPARγ receptors to promote adipocyte differentiation and beiging under certain conditions.

• The beiging process serves practical and therapeutic purposes: activating beiging can increase energy expenditure, promote fat uptake and oxidation, reduce blood glucose and lipid levels, improve insulin sensitivity, and potentially protect against obesity and type 2 diabetes.

Developmental origins and lineage potential

• Brown adipocytes (classic BAT) are derived from Myf5-positive progenitors, a lineage shared with skeletal muscle. This Myf5 lineage distinction aligns BAT with a myogenic-like origin.

• White adipocytes and beige adipocytes can originate from PDGFR-positive precursor cells, representing a distinct progenitor pool from the Myf5-positive lineage.

• Beige adipocytes arise through two routes: transdifferentiation from mature white adipocytes and de novo differentiation from PDGFR-positive precursors. After cold exposure ends, beige adipocytes may revert toward a white adipocyte phenotype, highlighting the plasticity of beiging.

• The term “beige transdifferentiation” reflects the ability of white adipocytes to acquire brown-like features (including UCP1 expression) and then potentially revert when the stimulus is removed.

Biomarkers and lineage-tracing approaches

• UCP1 serves as a primary functional biomarker for thermogenic adipocytes. Beige adipocytes can also express UCP1 under beiging stimuli.

• SHOX2 is investigated as a developmental marker that can label proliferative adipose progenitors involved in beiging, with evidence linking SHOX2-positive cells to beige adipogenesis.

• In the described studies, SHOX2-positive cells were tracked using reporter systems: a SHOX2 promoter driving membrane tdTomato or GFP to identify SHOX2-positive cells, and a SHOX2 promoter to label lineages in vivo.

• Baseline observations indicated SHOX2-positive cells constitute a minority under basal conditions (approximately 2%). After cold stimulation, SHOX2-positive cells increased to between 12% and 40% of observed adipocyte populations, indicating a proliferative/beiging response linked to SHOX2 expression.

• Imaging showed SHOX2-positive cells in adipose tissues, with red labeling marking lipid droplets within cells and green labeling marking SHOX2 expression. Cold treatment led to an increase in SHOX2-positive cells and beige markers, suggesting a role for SHOX2 in beiging dynamics.

• Over two weeks of stimulation, SHOX2-positive cell numbers continued to rise, but not all beige/beiging cells were SHOX2-positive, indicating heterogeneity and multiple origins for beige adipocytes.

Functional and genetic evidence for SHOX2 in beiging

• Experimental systems included conditional expression using SHOX2 reporters and knock-in strategies at the ROSA26 locus to manipulate SHOX2. In one approach, SHOX2 was inserted at ROSA26 and, upon promoter activation, led to overexpression of SHOX2 in targeted cells; this was used to assess the effect on UCP1 and beige adipocyte formation.

• When SHOX2 was conditionally expressed or manipulated, UCP1 expression decreased by about 50% after cold stimulation, consistent with SHOX2 acting as a later-stage regulator that can limit UCP1 expression at a mature adipogenic stage. This observation aligns with the idea that UCP1 marks an early commitment to the thermogenic program, while SHOX2 appears to influence later maturation steps.

• A “triple qPCR” (qPCR) analysis of mature and immature adipocytes revealed that after beiging stimulation, markers of adipogenesis and thermogenic genes discriminated between SHOX2-positive and SHOX2-negative populations, showing global downregulation of certain adipogenic and thermogenic genes in the SHOX2-manipulated context.

• ChIP-seq (chromatin immunoprecipitation sequencing) and expression analyses showed that SHOX2 can regulate PPARγ (PPARG) transcription, with peaks detected on the PPARG promoter. This supports a model in which SHOX2 acts to modulate adipocyte differentiation programs via PPARG regulation.

• SHOX2-ChIP-seq, qPCR, and luciferase assays provided evidence that SHOX2 directly controls PPARG transcription, thereby influencing adipogenesis and beiging potential.

Two sources of beiging and lineage tracing experiments

• Beiging arises from two main sources:
  1) Transdifferentiation of mature white adipocytes into beige-like adipocytes in response to stimuli (e.g., cold).
  2) Differentiation of precursor cells into beige adipocytes (de novo beiging from progenitors).

• After cold stimulation, some beige cells originate from SHOX2-positive progenitors, but not all beige cells are SHOX2-positive, indicating that multiple cellular sources contribute to beiging.

• Flow cytometry (flow sorting) was used to isolate SHOX2-positive stromal vascular cells (SVS) from white adipose tissue, confirming the enrichment of UCP1 and other thermogenic proteins in the SHOX2-positive subset during somatogenesis.

• Western blot analyses showed SHOX2-positive cells co-express UCP1 and ETC-related proteins (e.g., electron transport chain components) during somatogenesis, indicating a link between SHOX2 expression and a thermogenic phenotype at specific developmental windows.

• PDGFR-positive precursors can give rise to white and beige adipocytes, while Myf5-positive progenitors predominantly give rise to classical brown adipocytes. This supports a dual-origin model for beige adipocytes: both precursor-driven de novo differentiation and transdifferentiation from white adipocytes.

Developmental markers and early lineage signals

• SHOX2 is historically linked to heart and limb development, with SHOX2-positive cells serving as a marker for certain mesoderm-derived lineages. In adipose tissue studies, SHOX2 marks progenitor populations relevant to beiging and adipogenesis.

• Early development involves mesodermal lineage specification, with SHOX2 expression used to track progenitor contributions to adipose lineages.

• A key question raised was the role of SHOX2 in beiging: whether SHOX2 is present under basal conditions and how its presence or manipulation affects beiging efficiency.

• The basic experimental framework included labeling SHOX2-positive cells with fluorescent reporters to track lineage and using transcriptional and genomic analyses to connect SHOX2 to adipogenic programs.

Experimental design and key observations (summary of reported data)

• Baseline: SHOX2-positive cells comprise a small fraction (~2%) of adipose tissue under basal conditions.

• Cold stimulation kinetics: After four days of cold exposure, SHOX2-positive cells increased, and UCP1 and beige markers became detectable in SHOX2-positive cells. The labeled droplets and green SHOX2 signal indicated active beiging within these cells.

• After two weeks, SHOX2-positive cell numbers remained elevated, and beige adipocytes continued to emerge, but not all beige cells were SHOX2-positive, indicating heterogeneity of beiging origins.

• Inhibition/Knockout context: Under inhibition or SHOX2 loss conditions, baseline SHOX2 positivity remained low (approximately 2%), but with co-stimulation (cold + another stimulus), SHOX2-positive cells rose to 12%–40%, suggesting a promotive role of SHOX2 in beiging under certain stimulatory conditions.

• UCP1 and beige markers: UCP1 expression generally increased with beiging stimuli, but SHOX2 presence could modulate this, with later-stage SHOX2 activity associated with reduced UCP1 expression in some contexts, implying SHOX2 may act as a late-stage inhibitor of UCP1 during somatogenesis.

• Gene expression and PPARG regulation: qPCR showed a broad downregulation of adipogenic and beige gene expression following certain manipulations, consistent with SHOX2 suppressing late-stage beiging, while ChIP-seq and reporter assays demonstrated SHOX2 binding to PPARG promoter and direct regulation of PPARG transcription.

• Final interpretation: Beige adipogenesis has dual origins (transdifferentiation and de novo differentiation), with SHOX2 playing a crucial role in precursor-derived beige adipogenesis through PPARG regulation and limiting late-stage UCP1 expression; SHOX2-positive precursors contribute to beiging, while some beige adipocytes arise from SHOX2-negative lineages as well.

Functional implications and therapeutic potential

• Active beiging, via UCP1-mediated thermogenesis, can help reduce adiposity and improve metabolic parameters, including lowering blood glucose and triglyceride lipids, and enhancing insulin sensitivity. This suggests beiging as a potential strategy to combat obesity and type 2 diabetes.

• The dual-origin nature of beige adipocytes implies multiple cellular targets and windows for therapeutic intervention: promoting de novo beige differentiation from PDGFR-positive precursors or enhancing transdifferentiation of white adipocytes could both increase thermogenic capacity.

• SHOX2’s role as a regulator of PPARG and its apparent late-stage modulation of UCP1 expression points to the complexity of manipulating beiging: boosting precursor entry into beige programs while carefully coordinating late-stage thermogenic gene expression may be necessary for optimal metabolic benefits.

Sex differences and physiological relevance

• Some data indicate sex-specific differences in beiging: females show a higher prevalence of SHOX2-positive cells and a greater propensity for beige differentiation under basal conditions, suggesting sex hormones or other sex-linked factors influence the beiging capacity.

• This implies potential sex-specific responses to beiging-based therapies and underscores the need to study male and female subjects separately in future beiging research.

Experimental details and future directions

• Techniques used include fluorescence reporters (GFP, tdTomato) under the SHOX2 promoter to label SHOX2-positive cells, ROSA26-based gene insertion to manipulate SHOX2 expression, flow cytometry to sort SHOX2-positive adipocyte precursors, immunostaining to visualize UCP1 and beige markers, and sequencing-based approaches (ChIP-seq, RNA-seq, qPCR) to connect SHOX2 regulation to PPARG and adipogenic programs.

• The fraction of SHOX2-positive cells during beiging and their relation to UCP1 expression were quantified at different time points: basal (~2%), after 4 days cold exposure (increased SHOX2 and UCP1), and after two weeks (further increases but with a subset of beige cells SHOX2-negative).

• Data suggested SHOX2 acts as a later-stage inhibitor of UCP1 expression in mature adipocytes, while being necessary for certain precursor-derived beige differentiation via PPARG regulation.

• Presented future directions include proteomic identification of SHOX2 cofactors at various stages (precursor, maturing adipocytes, late somogenesis) using mass spectrometry; metabolic phenotyping (e.g., glucose tolerance, insulin sensitivity) in mice with SHOX2 manipulation; and translational work with human subcutaneous fat tissue to assess SHOX2 and UCP1 co-staining and potential sex differences.

• The practical question of how to maintain cold exposure and the experimental conditions to maximize beiging (e.g., sustained cold room exposure) is acknowledged as a key methodological consideration for future studies.

Summary of key takeaways

• Brown adipocytes are UCP1-rich and thermogenic, white adipocytes store energy, and beige adipocytes are inducible thermogenic cells that can arise from white adipocytes or progenitors.

• The beiging process is driven by hypothalamic-sympathetic signaling (NE → β-adrenergic receptors → cAMP → beiging genes and glycolysis) and can be modulated pharmacologically (e.g., PPARγ agonists like rosiglitazone).

• Beige adipogenesis has two origins: transdifferentiation of mature white adipocytes and de novo differentiation from PDGFR-positive progenitors; cold exposure induces beiging and increases UCP1 expression.

• SHOX2 is a developmental marker that labels SHOX2-positive progenitors contributing to beige adipogenesis, regulates PPARG transcription, and modulates late-stage UCP1 expression. Its expression increases with cold/beiging stimuli, but not all beige adipocytes are SHOX2-positive.

• Beige adipocytes have potential therapeutic value for obesity and metabolic syndrome, with sex differences suggesting higher beiging propensity in females.

• The beiging program is dynamic and reversible, highlighting the plasticity of adipose tissue and the importance of lineage context in adipocyte biology.